The risk of male breast cancer is also increased in the male carriers of such variants, particularly those in BRCA2, where the lifetime risk is approximately 8–10% when compared to BRCA1, where the risk is in the order of 1% [70]. The gene discussed is BRCA2; the disease is breast cancer.